Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2010 3
2011 1
2012 1
2013 1
2014 1
2016 1
2017 1
2019 6
2020 2
2022 3
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review.
Wainwright CL, Teixeira MM, Adelson DL, Buenz EJ, David B, Glaser KB, Harata-Lee Y, Howes MR, Izzo AA, Maffia P, Mayer AM, Mazars C, Newman DJ, Nic Lughadha E, Pimenta AM, Parra JA, Qu Z, Shen H, Spedding M, Wolfender JL. Wainwright CL, et al. Among authors: harata lee y. Pharmacol Res. 2022 Mar;177:106076. doi: 10.1016/j.phrs.2022.106076. Epub 2022 Jan 21. Pharmacol Res. 2022. PMID: 35074524 Free article. Review.
ACKR4 restrains antitumor immunity by regulating CCL21.
Whyte CE, Osman M, Kara EE, Abbott C, Foeng J, McKenzie DR, Fenix KA, Harata-Lee Y, Foyle KL, Boyle ST, Kochetkova M, Aguilera AR, Hou J, Li XY, Armstrong MA, Pederson SM, Comerford I, Smyth MJ, McColl SR. Whyte CE, et al. Among authors: harata lee y. J Exp Med. 2020 Jun 1;217(6):e20190634. doi: 10.1084/jem.20190634. J Exp Med. 2020. PMID: 32289156 Free PMC article.
Regulation of chemotactic networks by 'atypical' receptors.
Comerford I, Litchfield W, Harata-Lee Y, Nibbs RJ, McColl SR. Comerford I, et al. Among authors: harata lee y. Bioessays. 2007 Mar;29(3):237-47. doi: 10.1002/bies.20537. Bioessays. 2007. PMID: 17295321 Review.
An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease.
Comerford I, Bunting M, Fenix K, Haylock-Jacobs S, Litchfield W, Harata-Lee Y, Turvey M, Brazzatti J, Gregor C, Nguyen P, Kara E, McColl SR. Comerford I, et al. Among authors: harata lee y. Bioessays. 2010 Dec;32(12):1067-76. doi: 10.1002/bies.201000063. Epub 2010 Oct 15. Bioessays. 2010. PMID: 20954179 Review.
Corrigendum to "Future directions for the discovery of natural product-derived immunomodulating drugs: An IUPHAR positional review" [Pharmacol. Res. 177 (2022) 106076].
Wainwright CL, Teixeira MM, Adelson DL, Buenz EJ, David B, Glaser KB, Harata-Lee Y, Howes MR, Izzo AA, Maffia P, Mayer AMS, Mazars C, Newman DJ, Lughadha EN, Pimenta AMC, Parra JAA, Qu Z, Shen H, Spedding M, Wolfender JL. Wainwright CL, et al. Among authors: harata lee y. Pharmacol Res. 2022 Jun;180:106207. doi: 10.1016/j.phrs.2022.106207. Epub 2022 Apr 12. Pharmacol Res. 2022. PMID: 35428550 No abstract available.
Multiple functions of CXCL12 in a syngeneic model of breast cancer.
Williams SA, Harata-Lee Y, Comerford I, Anderson RL, Smyth MJ, McColl SR. Williams SA, et al. Among authors: harata lee y. Mol Cancer. 2010 Sep 17;9:250. doi: 10.1186/1476-4598-9-250. Mol Cancer. 2010. PMID: 20849618 Free PMC article.
20 results